BMO Capital analyst Joel Jackson is recommending investors buy Monsanto (NYSE: MON) given large merger spread/Jackson commented, "F2017/18E (Aug) estimates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE